iRhythm Technologies Management

Management Kriterienprüfungen 2/4

iRhythm Technologies' CEO ist Quentin Blackford , ernannt in Oct 2021, hat eine Amtszeit von 2.67 Jahren. Die jährliche Gesamtvergütung beträgt $16.60M , bestehend aus 4.1% Gehalt und 95.9% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.23% der Aktien des Unternehmens, im Wert von $6.92M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2 Jahre bzw. 6.9 Jahre.

Wichtige Informationen

Quentin Blackford

Geschäftsführender

US$16.6m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts4.1%
Amtszeit als Geschäftsführer2.8yrs
Eigentum des Geschäftsführers0.2%
Durchschnittliche Amtszeit des Managements2.1yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder7yrs

Jüngste Management Updates

Recent updates

iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt

May 13
iRhythm Technologies (NASDAQ:IRTC) Is Carrying A Fair Bit Of Debt

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Mar 25
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Business Is Trailing The Industry But Its Shares Aren't

Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

Feb 25
Here's What Analysts Are Forecasting For iRhythm Technologies, Inc. (NASDAQ:IRTC) After Its Annual Results

iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

Feb 02
iRhythm Technologies (NASDAQ:IRTC) Has Debt But No Earnings; Should You Worry?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 30% Below Their Intrinsic Value Estimate

iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Dec 20
iRhythm Technologies, Inc. (NASDAQ:IRTC) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable

Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Dec 02
Is Now An Opportune Moment To Examine iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Sep 20
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Aug 30
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Could Be 25% Below Their Intrinsic Value Estimate

When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Jul 04
When Should You Buy iRhythm Technologies, Inc. (NASDAQ:IRTC)?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Jun 16
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

May 26
Estimating The Intrinsic Value Of iRhythm Technologies, Inc. (NASDAQ:IRTC)

iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

May 08
iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S Is On The Mark

What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Mar 27
What Does iRhythm Technologies, Inc.'s (NASDAQ:IRTC) Share Price Indicate?

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Feb 25
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt Sensibly?

Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

Nov 24
Health Check: How Prudently Does iRhythm Technologies (NASDAQ:IRTC) Use Debt?

iRhythm falls after reaffirming 2022 guidance

Sep 21

iRhythm: Fairly Priced At Current Multiples, No Need To Size Up

Sep 02

Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

Aug 18
Is iRhythm Technologies (NASDAQ:IRTC) Using Debt In A Risky Way?

iRhythm Technologies Q2 results beat estimates, co raises FY 2022 revenue guidance

Aug 04

iRhythm Technologies provides FY22 prelims, commercial chief resigns

Jul 19

iRhythm: Reimbursement Overhang Squashed, Bull Thesis Back Intact

Jun 08

Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

Apr 14
Is iRhythm Technologies (NASDAQ:IRTC) A Risky Investment?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Quentin Blackford im Vergleich zu den Einnahmen von iRhythm Technologies verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2024n/an/a

-US$130m

Dec 31 2023US$17mUS$677k

-US$123m

Sep 30 2023n/an/a

-US$105m

Jun 30 2023n/an/a

-US$99m

Mar 31 2023n/an/a

-US$105m

Dec 31 2022US$8mUS$650k

-US$116m

Sep 30 2022n/an/a

-US$128m

Jun 30 2022n/an/a

-US$131m

Mar 31 2022n/an/a

-US$124m

Dec 31 2021US$10mUS$163k

-US$101m

Vergütung im Vergleich zum Markt: QuentinDie Gesamtvergütung ($USD16.60M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD6.83M).

Entschädigung vs. Einkommen: QuentinDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.


Geschäftsführer

Quentin Blackford (45 yo)

2.8yrs

Amtszeit

US$16,595,149

Vergütung

Mr. Quentin S. Blackford serves as an Independent Director of Paragon 28, Inc. since August 1, 2022. He serves as President and Chief Executive Officer since October 04, 2021 and serves as Director at iRhy...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Quentin Blackford
President2.8yrsUS$16.60m0.23%
$ 7.7m
Brice Bobzien
Chief Financial Officer1.9yrsUS$5.28m0.0085%
$ 282.1k
Minang Turakhia
Chief Medical & Scientific Officer and Executive VP of Product Innovation2.3yrsUS$5.32m0.011%
$ 369.5k
Patrick Murphy
Chief Business & Legal Officer2.6yrsUS$5.33m0.031%
$ 1.0m
Chad Patterson
Chief Commercial Officer2yrsUS$5.77m0.017%
$ 567.5k
Mervin Smith
Executive Vice President of Business Operationsless than a yearkeine Datenkeine Daten
Marc Rosenbaum
Senior VP of Finance & Chief Accounting Officerless than a yearkeine Daten0.0029%
$ 96.7k
Daniel Wilson
Executive VP of Corporate Development & Investor Relations5.1yrsUS$3.54m0.098%
$ 3.2m
Douglas Devine
Executive Advisor1.3yrsUS$2.72m0.055%
$ 1.8m
Sumi Shrishrimal
Executive VP & Chief Risk Officer2.2yrskeine Daten0.075%
$ 2.5m
Stephanie Zhadkevich
Director of Investor Relationsno datakeine Datenkeine Daten

2.1yrs

Durchschnittliche Betriebszugehörigkeit

45yo

Durchschnittliches Alter

Erfahrenes Management: IRTCDas Führungsteam des Unternehmens gilt als erfahren (2 Jahre durchschnittliche Betriebszugehörigkeit).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Quentin Blackford
President2.5yrsUS$16.60m0.23%
$ 7.7m
Ralph Snyderman
Independent Director7yrsUS$233.12k0.032%
$ 1.1m
Michael Mirro
Medical Director & Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Bruce Bodaken
Independent Director7yrsUS$240.25k0.030%
$ 1.0m
Abhijit Talwalkar
Independent Chairman8.2yrsUS$286.74k0.034%
$ 1.1m
R. Mead
Medical Director & Member of Scientific Advisory Boardno datakeine Datenkeine Daten
James Quinn
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Cathleen Noel Merz
Independent Director6.3yrsUS$230.62k0.019%
$ 614.5k
Mark Rubash
Independent Director8.3yrsUS$248.12k0.034%
$ 1.1m
Mehdi Razavi
Medical Director & Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Karen Ling
Independent Director2.7yrsUS$239.97k0.020%
$ 678.1k
Jay Alexander
Medical Director & Member of Scientific Advisory Boardno datakeine Datenkeine Daten

7.0yrs

Durchschnittliche Betriebszugehörigkeit

67yo

Durchschnittliches Alter

Erfahrener Vorstand: IRTCDie Vorstandsmitglieder gelten als erfahren (6.9 Jahre durchschnittliche Amtszeit).